These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 1055311

  • 1. LATS protector and abnormal thyroid stimulation in diffuse toxic goitre.
    Stewart RD.
    N Z Med J; 1975 Jan 08; 81(531):24. PubMed ID: 1055311
    [No Abstract] [Full Text] [Related]

  • 2. Correlation between long-acting thyroid stimulator protector level and thyroid 131-I uptake in thyrotoxicosis.
    Adams DD, Kennedy TH, Stewart RD.
    Br Med J; 1974 Apr 27; 2(5912):199-201. PubMed ID: 4406686
    [Abstract] [Full Text] [Related]

  • 3. Proceedings: Studies on long-acting thyroid stimulator protector in serum containing long-acting thyroid stimulator.
    Dirmikis S, Munro DS.
    J Endocrinol; 1975 Mar 27; 64(3):29P-30P. PubMed ID: 1173370
    [No Abstract] [Full Text] [Related]

  • 4. Thyroid suppressibility and long-acting thyroid stimulator in thyrotoxicosis.
    Silverstein GE, Burke G.
    Arch Intern Med; 1970 Oct 27; 126(4):615-20. PubMed ID: 4097002
    [No Abstract] [Full Text] [Related]

  • 5. Effects of long-acting thyroid stimulator (LATS) and LATS protector on human thyroid adenyl cyclase activity.
    Kendall-Taylor P.
    Br Med J; 1973 Jul 14; 3(5871):72-5. PubMed ID: 4740444
    [Abstract] [Full Text] [Related]

  • 6. Dissociation of serum LATS activity and hyperfunction and autonomy of the thyroid gland in Graves' disease.
    Hennemann G, Dolman A, Docter R, De Reus A, Van Zijl J.
    J Clin Endocrinol Metab; 1975 Jun 14; 40(6):935-41. PubMed ID: 1173367
    [Abstract] [Full Text] [Related]

  • 7. Isoelectric focusing of long-acting thyroid stimulator (LATS) containing IgG.
    Schleusener H, Adlkofer F, Uher L, Kaper-Czygan S, Kirstaedter HJ.
    Horm Metab Res; 1971 May 14; 3(3):221-2. PubMed ID: 5171402
    [No Abstract] [Full Text] [Related]

  • 8. Evolution of the concept of the pathogenesis of toxic diffuse goitre (Graves' disease) and an assessment of the long-acting thyroid stimulator (L.A.T.S.).
    Hassan HA.
    J Egypt Med Assoc; 1978 May 14; 61(1-2):111-20. PubMed ID: 583050
    [No Abstract] [Full Text] [Related]

  • 9. [The long acting thyroid stimulator (LATS) in some thyroid diseases. Preliminary results].
    Busnardo B, Accordi F, Debiasi S.
    Acta Isot (Padova); 1968 Oct 30; 8(2):165-79. PubMed ID: 5761578
    [No Abstract] [Full Text] [Related]

  • 10. [The determination of long-acting thyroid stimulator (LATS) in thyroid diseases].
    Depisch D, Höfer R, Schatz H.
    Wien Z Inn Med; 1968 Oct 30; 49(4):121-30. PubMed ID: 5757238
    [No Abstract] [Full Text] [Related]

  • 11. The effect of radioablation of the thyroid gland in Graves' disease with high levels of long-acting thyroid stimulator (LATS).
    Volpé R, Desbarats-Schonbaum ML, Schonbaum E, Row VV, Ezrin C.
    Am J Med; 1969 Feb 30; 46(2):217-26. PubMed ID: 5818477
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].
    Lamberg BA, Gordin A.
    Nord Med; 1968 Dec 05; 80(49):1651-7. PubMed ID: 5757398
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma LATS and thyroid antibody level, and the clinical manifestations of Graves' disease.
    Földes J, Takó J, Bános C, Gesztesi E, Varga I.
    Acta Med Acad Sci Hung; 1969 Dec 05; 26(3):233-43. PubMed ID: 5395883
    [No Abstract] [Full Text] [Related]

  • 20. [Standardization of the radiobiological method for determination of long-acting thyroid stimulator (LATS) in human serum].
    Muramoto E, Nicolau W, Ikeda E, de Assis LM, Pieroni RR.
    AMB Rev Assoc Med Bras; 1972 Oct 05; 18(10):379-88. PubMed ID: 4539360
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.